HIV-ASSIST: A New Tool to Guide Evidence-Based Selection of Antiretroviral Therapy

How the HIV-ASSIST tool can help address challenging treatment issues in a complex patient population with HIV and LTBI

Nicky Mehtani, MD, MPH Released: February 22, 2021

In this interactive multimedia module, expert faculty introduce the HIV-ASSIST decision support tool and demonstrate its use in clinical decision-making.

Jonathan Li, MD Maunank Shah, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ US Physicians: maximum of 0.75 Medical Knowledge MOC point(s) Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Physician Assistants: maximum of 0.75 hours of AAPA Category I CME credits Released: February 4, 2021 Expired: February 3, 2022

Why Use HIV-ASSIST?

How HIV-ASSIST Works

Validation of the HIV-ASSIST Tool

Case 1: Initiating ART in a Treatment-Naive Patient

Case 2: Initiating ART in a Treatment-Naive Patient With Comorbidities and Drug–Drug Interactions

Case 3: Switching ART in a Treatment-Experienced Patient With Viremia and ARV Resistance Mutations

In these slides, expert faculty introduce the HIV-ASSIST decision support tool and demonstrate its use in clinical decision-making.

Jonathan Li, MD Maunank Shah, MD Released: February 4, 2021